Shareholders' Equity

9 Months Ended

Sep. 30, 2023

Shareholders' Equity

Shareholders' Equity

8. Shareholders' Equity

	Three months ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
Common stock and additional paid-in capital
Balance, beginning of period	$	46,003		$	74,885		$	74,934		$	72,817
Dividends paid		—			—			(28,979	)		—
Issuance of common stock and warrants, net		—			—			—			2,000
Share-based compensation expense		33			24			80			90
Proceeds from employee stock purchase plan		3			1			4			3
Balance, end of period	$	46,039		$	74,910		$	46,039		$	74,910
Accumulated other comprehensive loss
Balance, beginning of period	$	(270	)	$	(266	)	$	(288	)	$	(241	)
Unrealized loss on available-for-sale securities, net of tax		(31	)		—			(17	)		(2	)
Foreign currency translation adjustment		(7	)		(22	)		(3	)		(45	)
Balance, end of period	$	(308	)	$	(288	)	$	(308	)	$	(288	)
Accumulated deficit
Balance, beginning of period	$	(2,367	)	$	(23,296	)	$	(516	)	$	(21,072	)
Net loss		(1,351	)		(1,248	)		(3,202	)		(3,472	)
Balance, end of period	$	(3,718	)	$	(24,544	)	$	(3,718	)	$	(24,544	)
Total shareholders' equity	$	42,013		$	50,078		$	42,013		$	50,078

Issue of Common Stock and Warrants

On September 12, 2021, the Company entered into a securities purchase agreement with certain purchasers named therein, pursuant to which the Company issued 3,623,189 shares of the Company's common stock, par value $0.001 per share at an offering price of $2.76 per share. The Company received gross proceeds of approximately $10,000 and net proceeds of $9,288 after deducting placement agent fees and related offering expenses. In a concurring private placement the Company also issued to the same purchasers warrants exercisable for an aggregate of 3,623,189 shares of common stock at an exercise price of $2.76 per share. Each warrant became immediately exercisable and will expire on March 15, 2027.

On January 4, 2022, the Company entered into a Securities Purchase Agreement with Edward D. Bagley, an affiliate of the Company, pursuant to which the Company agreed to issue and sell, in a private placement 1,538,461 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price of $1.30 per share of Common Stock. The consideration for the Shares is the cancellation and termination of Mr. Bagley’s outstanding bridge loan to the Company in the principal amount of $2,000 originally issued on July 2, 2021 and amended and restated on September 11, 2021. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder.

Cash Dividend Distribution

On May 8, 2023, the Company announced that the Company’s Board of Directors had declared a special one-time cash dividend of $1.00 per share of the Company’s common stock or eligible warrants and paid $28,978 of cash dividends on May 31, 2023 to shareholders of record on May 22, 2023. 

Nasdaq Delisting Notification

On August 1, 2023, the Company received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) informing management that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), the Company was granted a period of 180 calendar days from August 1, 2023, or until January 29, 2024, to regain compliance with the Minimum Bid Price Requirement. The Company’s common stock has continued to trade below $1.00 per share.